Pedro Alamo is an experienced procurement and logistics professional currently serving as the Head of Procurement & Logistics at the CNIO - Spanish National Cancer Research Centre since March 2023. Previous roles include Procurement Consultant at the United Nations Population Fund (UNFPA) from February 2022 to February 2023 and Head of Procurement & Logistics at CNIO from March 2014 to March 2022. Additionally, Pedro has extensive experience as a Procurement Consultant with UNDP and as a Trade Advisor at the Economic and Commercial Office of the Embassy of Spain. Pedro began the professional journey at Honeywell SL in corporate finance services. Educational qualifications include a Master in International Business Management from CECO and an MSc in Business Management and Administration from Universidad Complutense de Madrid, complemented by studies at De Haagse Hogeschool.
This person is not in the org chart
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.